Opportunity Alert: Stocks from India's Emerging Businesses
Here is the latest financial fact sheet of ALKEM LABORATORIES. For more details, see the ALKEM LABORATORIES quarterly results and ALKEM LABORATORIES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.6 |
No. of shares | m | 119.57 |
1 Week | % | 2.3 |
1 Month | % | -3.7 |
1 Year | % | 7.2 |
52 week H/L | Rs | 3,624.8/2,835.1 |
No. of Mths Year Ending |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
5-Yr Chart Click to enlarge
|
---|
ALKEM LABORATORIES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 2,468 | 2,265 | 2,720 | 3,150 | 4,068 | |
Low | Rs | 1,578 | 1,693 | 1,660 | 2,224 | 2,671 | |
Sales per share (Unadj.) | Rs | 533.8 | 615.3 | 697.9 | 741.4 | 889.4 | |
Earnings per share (Unadj.) | Rs | 53.4 | 64.7 | 96.1 | 135.3 | 140.5 | |
Diluted earnings per share | Rs | 53.4 | 64.7 | 96.1 | 135.3 | 140.5 | |
Cash flow per share (Unadj.) | Rs | 65.4 | 80.9 | 117.3 | 158.3 | 166.0 | |
Dividends per share (Unadj.) | Rs | 13.00 | 16.00 | 25.00 | 30.00 | 34.00 | |
Adj. dividends per share | Rs | 13.00 | 16.00 | 25.00 | 30.00 | 34.00 | |
Avg Dividend yield | % | 0.6 | 0.8 | 1.1 | 1.1 | 1.0 | |
Book value per share (Unadj.) | Rs | 406.7 | 454.8 | 515.1 | 616.8 | 722.4 | |
Adj. book value per share | Rs | 406.7 | 454.8 | 515.1 | 616.9 | 722.4 | |
Shares outstanding (eoy) | m | 119.57 | 119.57 | 119.57 | 119.57 | 119.57 | |
Price / Sales ratio | x | 3.8 | 3.2 | 3.1 | 3.6 | 3.8 | |
Avg P/E ratio | x | 37.9 | 30.6 | 22.8 | 19.9 | 24.0 | |
P/CF ratio (eoy) | x | 31.0 | 24.5 | 18.7 | 17.0 | 20.3 | |
Price / Book Value ratio | x | 5.0 | 4.4 | 4.3 | 4.4 | 4.7 | |
Dividend payout | % | 24.3 | 24.7 | 26.0 | 22.2 | 24.2 | |
Avg Mkt Cap | Rs m | 241,880 | 236,619 | 261,868 | 321,244 | 402,868 | |
Total wages/salary | Rs m | 11,916 | 13,625 | 15,055 | 16,210 | 19,627 |
ALKEM LABORATORIES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 63,825 | 73,572 | 83,444 | 88,650 | 106,342 | |
Other income | Rs m | 1,154 | 877 | 1,042 | 2,332 | 1,627 | |
Total revenues | Rs m | 64,979 | 74,449 | 84,486 | 90,982 | 107,968 | |
Gross profit | Rs m | 10,089 | 11,148 | 14,734 | 19,424 | 20,380 | |
Depreciation | Rs m | 1,430 | 1,932 | 2,528 | 2,746 | 3,040 | |
Interest | Rs m | 553 | 546 | 651 | 589 | 524 | |
Profit before tax | Rs m | 9,260 | 9,547 | 12,598 | 18,421 | 18,443 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 2,876 | 1,810 | 1,105 | 2,243 | 1,640 | |
Profit after tax | Rs m | 6,384 | 7,736 | 11,493 | 16,178 | 16,803 | |
Gross profit margin | % | 15.8 | 15.2 | 17.7 | 21.9 | 19.2 | |
Effective tax rate | % | 31.1 | 19.0 | 8.8 | 12.2 | 8.9 | |
Net profit margin | % | 10.0 | 10.5 | 13.8 | 18.2 | 15.8 |
ALKEM LABORATORIES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 40,132 | 42,044 | 55,057 | 69,233 | 84,337 | |
Current liabilities | Rs m | 23,833 | 22,175 | 32,446 | 36,041 | 48,053 | |
Net working cap to sales | % | 25.5 | 27.0 | 27.1 | 37.4 | 34.1 | |
Current ratio | x | 1.7 | 1.9 | 1.7 | 1.9 | 1.8 | |
Inventory Days | Days | 39 | 24 | 18 | 20 | 42 | |
Debtors Days | Days | 62 | 62 | 72 | 66 | 65 | |
Net fixed assets | Rs m | 29,968 | 32,844 | 35,073 | 34,825 | 43,245 | |
Share capital | Rs m | 239 | 239 | 239 | 239 | 239 | |
"Free" reserves | Rs m | 48,389 | 54,139 | 61,354 | 73,517 | 86,134 | |
Net worth | Rs m | 48,628 | 54,378 | 61,593 | 73,756 | 86,373 | |
Long term debt | Rs m | 1,307 | 2,313 | 739 | 279 | 94 | |
Total assets | Rs m | 70,100 | 75,006 | 90,130 | 104,114 | 127,599 | |
Interest coverage | x | 17.7 | 18.5 | 20.4 | 32.3 | 36.2 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.9 | 1.0 | 0.9 | 0.9 | 0.8 | |
Return on assets | % | 9.9 | 11.0 | 13.5 | 16.1 | 13.6 | |
Return on equity | % | 13.1 | 14.2 | 18.7 | 21.9 | 19.5 | |
Return on capital | % | 19.7 | 17.8 | 21.3 | 25.7 | 21.9 | |
Exports to sales | % | 17.6 | 16.6 | 19.2 | 22.1 | 18.7 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 11,259 | 12,238 | 16,061 | 19,555 | 19,924 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 11,259 | 12,238 | 16,061 | 19,555 | 19,924 | |
Fx outflow | Rs m | 2,103 | 2,105 | 2,483 | 2,467 | 3,911 | |
Net fx | Rs m | 9,156 | 10,133 | 13,578 | 17,088 | 16,013 |
ALKEM LABORATORIES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2,660 | 7,797 | 5,851 | 12,649 | 11,110 | |
From Investments | Rs m | -3,572 | -3,164 | -7,414 | -9,985 | -14,351 | |
From Financial Activity | Rs m | 846 | -3,789 | 792 | -2,718 | 3,796 | |
Net Cashflow | Rs m | 1 | 823 | -731 | -17 | 580 |
Share Holding
Shareholding as on Mar 2023
|
Company Information
|
CHM: Basudeo N Singh | COMP SEC: Manish Narang | YEAR OF INC: 1973 | BSE CODE: 539523 | FV (Rs): 2 | DIV YIELD (%): 1.0 |
More Pharmaceuticals Company Fact Sheets: AUROBINDO PHARMA CIPLA PIRAMAL ENTERPRISES LUPIN ZYDUS LIFESCIENCES
Compare ALKEM LABORATORIES With: AUROBINDO PHARMA CIPLA PIRAMAL ENTERPRISES LUPIN ZYDUS LIFESCIENCES
On Thursday, Indian share markets remained subdued throughout the session and ended lower.